SGMOQ Insider Transactions — Page 2
1,473 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–200; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Herberts Curt A. III | Senior VP & CBO | 2017-05-12 | Sale | 2,000.0 | $8.5 |
| Herberts Curt A. III | Senior VP & CBO | 2017-05-11 | Sale | 639.0 | $6.5 |
| LANPHIER EDWARD O II | President & CEO | 2015-07-15 | Sale | 25,000.0 | $10.43 |
| Wolff Henry Ward | Exec VP & CFO | 2015-07-13 | Sale | 2,000.0 | $10.0 |
| Wolff Henry Ward | Exec VP & CFO | 2015-07-13 | Sale | 3,898.0 | $10.0 |
| Wolff Henry Ward | Exec VP & CFO | 2015-07-10 | Sale | 6,102.0 | $10.0 |
| LANPHIER EDWARD O II | President & CEO | 2015-06-15 | Sale | 25,000.0 | $11.08 |
| Wolff Henry Ward | Exec VP & CFO | 2015-06-10 | Sale | 2,000.0 | $12.21 |
| Wolff Henry Ward | Exec VP & CFO | 2015-06-10 | Sale | 10,000.0 | $12.21 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2015-06-05 | Sale | 15,000.0 | $12.29 |
| RINGO WILLIAM R | Director | 2015-06-03 | Sale | 2,200.0 | $12.44 |
| Gregory Philip D | SVP of Research & CSO | 2015-06-01 | Sale | 15,000.0 | $12.39 |
| LANPHIER EDWARD O II | President & CEO | 2015-05-15 | Sale | 25,000.0 | $11.51 |
| Wolff Henry Ward | Exec VP & CFO | 2015-05-11 | Sale | 2,000.0 | $13.25 |
| Wolff Henry Ward | Exec VP & CFO | 2015-05-11 | Sale | 10,000.0 | $13.25 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2015-05-05 | Sale | 15,000.0 | $12.29 |
| RINGO WILLIAM R | Director | 2015-05-04 | Sale | 3,000.0 | $12.98 |
| Gregory Philip D | SVP of Research & CSO | 2015-05-01 | Sale | 15,000.0 | $12.62 |
| LANPHIER EDWARD O II | President & CEO | 2015-04-15 | Sale | 25,000.0 | $15.33 |
| Wolff Henry Ward | Exec VP & CFO | 2015-04-10 | Sale | 1,029.0 | $15.37 |
| Wolff Henry Ward | Exec VP & CFO | 2015-04-10 | Sale | 971.0 | $15.43 |
| Wolff Henry Ward | Exec VP & CFO | 2015-04-10 | Sale | 10,000.0 | $15.3 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2015-04-06 | Sale | 15,000.0 | $14.94 |
| RINGO WILLIAM R | Director | 2015-04-06 | Sale | 2,200.0 | $14.95 |
| Gregory Philip D | SVP of Research & CSO | 2015-04-01 | Sale | 15,000.0 | $15.15 |
| Wolff Henry Ward | Exec VP & CFO | 2015-03-19 | Sale | 10,000.0 | $18.0 |
| LANPHIER EDWARD O II | President & CEO | 2015-03-16 | Sale | 25,000.0 | $17.29 |
| Wolff Henry Ward | Exec VP & CFO | 2015-03-10 | Sale | 2,000.0 | $16.68 |
| Wolff Henry Ward | Exec VP & CFO | 2015-03-10 | Sale | 10,000.0 | $16.68 |
| Mento Steven J | Director | 2015-03-05 | Sale | 6,501.0 | $18.3 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2015-03-05 | Sale | 15,000.0 | $18.29 |
| Wolff Henry Ward | Exec VP & CFO | 2015-03-04 | Sale | 10,000.0 | $18.0 |
| RINGO WILLIAM R | Director | 2015-03-03 | Sale | 2,200.0 | $17.21 |
| Gregory Philip D | SVP of Research & CSO | 2015-03-02 | Sale | 15,000.0 | $17.26 |
| LANPHIER EDWARD O II | President & CEO | 2015-02-17 | Sale | 25,000.0 | $15.69 |
| Ramasastry Saira | Director | 2015-02-12 | Sale | 10,000.0 | $15.0 |
| Wolff Henry Ward | Exec VP & CFO | 2015-02-10 | Sale | 1,029.0 | $12.65 |
| Wolff Henry Ward | Exec VP & CFO | 2015-02-10 | Sale | 971.0 | $12.63 |
| Wolff Henry Ward | Exec VP & CFO | 2015-02-10 | Sale | 10,000.0 | $12.65 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2015-02-05 | Sale | 15,000.0 | $12.93 |
| RINGO WILLIAM R | Director | 2015-02-03 | Sale | 2,200.0 | $12.7 |
| Gregory Philip D | SVP of Research & CSO | 2015-02-02 | Sale | 15,000.0 | $12.86 |
| LANPHIER EDWARD O II | President & CEO | 2015-01-16 | Sale | 10,000.0 | $14.29 |
| LANPHIER EDWARD O II | President & CEO | 2015-01-15 | Sale | 1,600.0 | $14.97 |
| LANPHIER EDWARD O II | President & CEO | 2015-01-15 | Sale | 13,400.0 | $14.09 |
| Wolff Henry Ward | Exec VP & CFO | 2015-01-12 | Sale | 2,000.0 | $15.87 |
| Wolff Henry Ward | Exec VP & CFO | 2015-01-12 | Sale | 10,000.0 | $15.87 |
| RINGO WILLIAM R | Director | 2015-01-05 | Sale | 2,200.0 | $15.2 |
| LARSON JOHN WILLIAM | Director | 2015-01-05 | Sale | 15,000.0 | $15.1 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2015-01-05 | Sale | 600.0 | $15.66 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2015-01-05 | Sale | 14,400.0 | $15.17 |
| Gregory Philip D | SVP, Research & CSO | 2015-01-02 | Sale | 15,000.0 | $15.78 |
| LANPHIER EDWARD O II | President & CEO | 2014-12-15 | Sale | 16,000.0 | $14.79 |
| LANPHIER EDWARD O II | President & CEO | 2014-12-15 | Sale | 9,000.0 | $16.47 |
| LARSON JOHN WILLIAM | Director | 2014-12-15 | Sale | 10,000.0 | $16.28 |
| Mento Steven J | Director | 2014-12-11 | Sale | 6,354.0 | $15.0 |
| LARSON JOHN WILLIAM | Director | 2014-12-09 | Sale | 10,000.0 | $12.0 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2014-12-05 | Sale | 15,000.0 | $11.21 |
| Gregory Philip D | SVP of Research & CSO | 2014-12-01 | Sale | 15,000.0 | $11.68 |
| LANPHIER EDWARD O II | President & CEO | 2014-11-17 | Sale | 25,000.0 | $11.23 |
| LARSON JOHN WILLIAM | Director | 2014-11-12 | Sale | 10,000.0 | $12.0 |
| Wolff Henry Ward | Exec VP & CFO | 2014-11-10 | Sale | 2,000.0 | $11.37 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2014-11-05 | Sale | 15,000.0 | $11.35 |
| Gregory Philip D | SVP of Research & CSO | 2014-11-03 | Sale | 15,000.0 | $11.91 |
| LARSON JOHN WILLIAM | Director | 2014-10-28 | Sale | 10,000.0 | $12.02 |
| LANPHIER EDWARD O II | President & CEO | 2014-10-15 | Sale | 25,000.0 | $10.49 |
| Wolff Henry Ward | Exec VP & CFO | 2014-10-10 | Sale | 2,000.0 | $10.1 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2014-10-06 | Sale | 15,000.0 | $10.72 |
| Gregory Philip D | SVP of Research & CSO | 2014-10-01 | Sale | 15,000.0 | $10.8 |
| LANPHIER EDWARD O II | President & CEO | 2014-09-15 | Sale | 25,000.0 | $12.14 |
| Wolff Henry Ward | Exec VP & CFO | 2014-09-10 | Sale | 2,000.0 | $12.31 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2014-09-05 | Sale | 15,000.0 | $12.2 |
| LARSON JOHN WILLIAM | Director | 2014-09-04 | Sale | 10,000.0 | $12.81 |
| Gregory Philip D | SVP of Research & CSO | 2014-09-02 | Sale | 15,000.0 | $13.45 |
| LANPHIER EDWARD O II | President & CEO | 2014-08-15 | Sale | 25,000.0 | $13.95 |
| Wolff Henry Ward | Exec VP & CFO | 2014-08-11 | Sale | 2,000.0 | $14.14 |
| Wolff Henry Ward | Exec VP & CFO | 2014-08-11 | Sale | 8,000.0 | $14.17 |
| Ramasastry Saira | Director | 2014-08-08 | Sale | 10,000.0 | $14.0 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2014-08-05 | Sale | 1,798.0 | $12.98 |
| ANDO DALE G | VP, Therapeutic Dev. & CMO | 2014-08-05 | Sale | 13,202.0 | $12.99 |
| LARSON JOHN WILLIAM | Director | 2014-08-04 | Sale | 10,000.0 | $12.56 |
| RA Capital Healthcare Fund LP | Other | 2014-08-01 | Sale | 27,770.0 | $12.82 |
| RA CAPITAL MANAGEMENT, LLC | Other | 2014-08-01 | Sale | 27,770.0 | $12.82 |
| Kolchinsky Peter | Other | 2014-08-01 | Sale | 27,770.0 | $12.82 |
| Gregory Philip D | SVP of Research & CSO | 2014-08-01 | Sale | 15,000.0 | $12.54 |
| RA Capital Healthcare Fund LP | Other | 2014-07-30 | Sale | 31,108.0 | $12.59 |
| RA CAPITAL MANAGEMENT, LLC | Other | 2014-07-30 | Sale | 31,108.0 | $12.59 |
| Kolchinsky Peter | Other | 2014-07-30 | Sale | 31,108.0 | $12.59 |
| RA Capital Healthcare Fund LP | Other | 2014-07-30 | Sale | 57,890.0 | $12.36 |
| RA CAPITAL MANAGEMENT, LLC | Other | 2014-07-30 | Sale | 57,890.0 | $12.36 |
| Kolchinsky Peter | Other | 2014-07-30 | Sale | 57,890.0 | $12.36 |
| RA Capital Healthcare Fund LP | Other | 2014-07-30 | Sale | 20,592.0 | $12.35 |
| RA CAPITAL MANAGEMENT, LLC | Other | 2014-07-30 | Sale | 20,592.0 | $12.35 |
| Kolchinsky Peter | Other | 2014-07-30 | Sale | 20,592.0 | $12.35 |
| RA Capital Healthcare Fund LP | Other | 2014-07-29 | Sale | 1,407.0 | $12.41 |
| RA CAPITAL MANAGEMENT, LLC | Other | 2014-07-29 | Sale | 1,407.0 | $12.41 |
| Kolchinsky Peter | Other | 2014-07-29 | Sale | 1,407.0 | $12.41 |
| RA Capital Healthcare Fund LP | Other | 2014-07-28 | Sale | 35,271.0 | $12.11 |
| RA CAPITAL MANAGEMENT, LLC | Other | 2014-07-28 | Sale | 35,271.0 | $12.11 |
| Kolchinsky Peter | Other | 2014-07-28 | Sale | 35,271.0 | $12.11 |